Last reviewed · How we verify

Enteral nutrition

Sichuan Cancer Hospital and Research Institute · FDA-approved active Small molecule Quality 2/100

Enteral nutrition is a Small molecule drug developed by Sichuan Cancer Hospital and Research Institute. It is currently FDA-approved. Also known as: Peptisorb, Nutricia Ltd, Netherlands, nutrition.

At a glance

Generic nameEnteral nutrition
Also known asPeptisorb, Nutricia Ltd, Netherlands, nutrition
SponsorSichuan Cancer Hospital and Research Institute
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Enteral nutrition

What is Enteral nutrition?

Enteral nutrition is a Small molecule drug developed by Sichuan Cancer Hospital and Research Institute.

Who makes Enteral nutrition?

Enteral nutrition is developed and marketed by Sichuan Cancer Hospital and Research Institute (see full Sichuan Cancer Hospital and Research Institute pipeline at /company/sichuan-cancer-hospital-and-research-institute).

Is Enteral nutrition also known as anything else?

Enteral nutrition is also known as Peptisorb, Nutricia Ltd, Netherlands, nutrition.

What development phase is Enteral nutrition in?

Enteral nutrition is FDA-approved (marketed).

Related